世界の心血管遺伝子検査市場は2023年に約90億7,000万米ドルと評価され、2024年から2032年の予測期間にわたって11.2%を超える健全な成長率で成長すると予想されています。
心血管遺伝子検査は、冠動脈疾患、高血圧、心筋症、その他の関連疾患を含むさまざまな心血管疾患に対する個人の遺伝的リスクを評価するためのますます重要なツールとなっています。心血管疾患の罹患率は世界的に急速に増加しているため、遺伝子検査による早期発見は、対象を絞った予防措置の実施を促進し、これらの疾患に関連する罹患率と死亡率を低減します。
心血管疾患、特に冠動脈疾患（CAD）の発生率の上昇は、心血管遺伝子検査市場の成長を牽引する重要な要因です。心血管疾患による死亡者数は毎年1,860万人と推定されており、早期検出方法の需要が高まっています。世界保健機関（WHO）によると、心血管疾患は依然として世界中で死亡原因の第1位であり、毎年約1,790万人が死亡しています。さらに、予測によれば、2030年までにこの数は2,300万を超える可能性があり、心血管治療における遺伝子検査などの高度な診断ツールが極めて重要であることが強調されています。さらに、カテーテルベースの介入やロボット支援手術などの低侵襲技術の採用が増え、心血管治療の適用範囲が拡大しています。これらの進歩により、回復時間の短縮、合併症リスクの低減、入院期間の短縮など、数多くの利点がもたらされ、心血管遺伝子検査の需要が高まっています。
世界の市場は、健康増進と予防医療の取り組みの拡大からも恩恵を受けています。予防医療が普及するにつれ、心血管疾患の遺伝的リスク要因を理解することに関心を持つ人が増加しています。公衆衛生キャンペーンや教育の取り組みにより、積極的な医療の重要性に対する認識が高まり、遺伝子検査の需要が高まっています。しかし、市場は、データの管理と解釈の複雑さ、機密性の高い遺伝情報の取り扱いに伴う倫理的およびプライバシー上の懸念など、課題に直面しています。これらの要因は、市場の成長を妨げる可能性があります。
世界の心血管遺伝子検査市場は、地理的に北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、その他の地域に分かれています。北アメリカが市場を支配しており、患者数が多く革新的な治療法に対する需要が高いアメリカがこの地域をリードしています。有利な償還ポリシーと主要な市場プレーヤーの存在が、この地域の市場をさらに強化しています。一方、アジア太平洋地域は、心血管疾患に対する意識の高まり、医療インフラの拡大、中国やインドなどの人口密度の高い国での罹患率の増加により、大幅な成長が見込まれています。この地域の市場は、小売薬局数の増加と医療サービスへのアクセスの改善によっても牽引されています。
目次
Table of Contents
Chapter 1. Global Cardiovascular Genetic Testing Market Executive Summary
1.1. Global Cardiovascular Genetic Testing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Disease
1.3.2. By Technology
1.3.3. By Testing Type
1.3.4. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Cardiovascular Genetic Testing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Cardiovascular Genetic Testing Market Dynamics
3.1. Market Drivers
3.1.1. Rising Incidence of Cardiovascular Diseases
3.1.2. Increasing Utilization of Minimally Invasive Techniques
3.2. Market Challenges
3.2.1. Data Management and Interpretation
3.2.2. Patient and Provider Acceptance
3.3. Market Opportunities
3.3.1. Improved Healthcare Access and Affordability
3.3.2. Wellness and Preventive Health Initiatives
Chapter 4. Global Cardiovascular Genetic Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Cardiovascular Genetic Testing Market Size & Forecasts by Disease (2022-2032)
5.1. Segment Dashboard
5.2. Global Cardiovascular Genetic Testing Market: Disease Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Inherited Cardiomyopathies
5.2.2. Hypertrophic Cardiomyopathy (HCM)
5.2.3. Dilated Cardiomyopathy (DCM)
5.2.4. Arrhythmia
5.2.5. Aortopathies
5.2.6. Others
Chapter 6. Global Cardiovascular Genetic Testing Market Size & Forecasts by Technology (2022-2032)
6.1. Segment Dashboard
6.2. Global Cardiovascular Genetic Testing Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Cytogenetic Testing
6.2.2. Biochemical Testing
6.2.3. Molecular Testing
Chapter 7. Global Cardiovascular Genetic Testing Market Size & Forecasts by Testing Type (2022-2032)
7.1. Segment Dashboard
7.2. Global Cardiovascular Genetic Testing Market: Testing Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Predictive Testing
7.2.2. Carrier Testing
7.2.3. Prenatal and Newborn Testing
7.2.4. Diagnostic Testing
7.2.5. Pharmacogenomic Testing
7.2.6. Others
Chapter 8. Global Cardiovascular Genetic Testing Market Size & Forecasts by Application (2022-2032)
8.1. Segment Dashboard
8.2. Global Cardiovascular Genetic Testing Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Chromosome Analysis
8.2.2. Genetic Disease Diagnosis
8.2.3. Cardiovascular Disease Diagnosis
8.2.4. Others
Chapter 9. Global Cardiovascular Genetic Testing Market Size & Forecasts by Region (2022-2032)
9.1. North America Cardiovascular Genetic Testing Market
9.1.1. U.S. Cardiovascular Genetic Testing Market
9.1.1.1. Disease Breakdown Size & Forecasts, 2022-2032
9.1.1.2. Technology Breakdown Size & Forecasts, 2022-2032
9.1.1.3. Testing Type Breakdown Size & Forecasts, 2022-2032
9.1.1.4. Application Breakdown Size & Forecasts, 2022-2032
9.1.2. Canada Cardiovascular Genetic Testing Market
9.2. Europe Cardiovascular Genetic Testing Market
9.2.1. U.K. Cardiovascular Genetic Testing Market
9.2.2. Germany Cardiovascular Genetic Testing Market
9.2.3. France Cardiovascular Genetic Testing Market
9.2.4. Spain Cardiovascular Genetic Testing Market
9.2.5. Italy Cardiovascular Genetic Testing Market
9.2.6. Rest of Europe Cardiovascular Genetic Testing Market
9.3. Asia-Pacific Cardiovascular Genetic Testing Market
9.3.1. China Cardiovascular Genetic Testing Market
9.3.2. India Cardiovascular Genetic Testing Market
9.3.3. Japan Cardiovascular Genetic Testing Market
9.3.4. Australia Cardiovascular Genetic Testing Market
9.3.5. South Korea Cardiovascular Genetic Testing Market
9.3.6. Rest of Asia Pacific Cardiovascular Genetic Testing Market
9.4. Latin America Cardiovascular Genetic Testing Market
9.4.1. Brazil Cardiovascular Genetic Testing Market
9.4.2. Mexico Cardiovascular Genetic Testing Market
9.4.3. Rest of Latin America Cardiovascular Genetic Testing Market
9.5. Middle East & Africa Cardiovascular Genetic Testing Market
9.5.1. Saudi Arabia Cardiovascular Genetic Testing Market
9.5.2. South Africa Cardiovascular Genetic Testing Market
9.5.3. Rest of Middle East & Africa Cardiovascular Genetic Testing Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Bio-Rad Laboratories Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Danaher
10.3.3. Thermo Fisher Scientific, Inc.
10.3.4. Daan Gene Co., Ltd.
10.3.5. F. Hoffmann-La Roche, Ltd.
10.3.6. Genentech, Inc.
10.3.7. Genomictree, Inc.
10.3.8. HTG Molecular Diagnostics, Inc.
10.3.9. Illumina, Inc.
10.3.10. Integragen
10.3.11. Laboratory Corporation of America Holdings
10.3.12. Luminex Corporation
10.3.13. Molecular MD Corp.
10.3.14. Myriad Genetics, Inc.
10.3.15. Natera, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
List of Tables
TABLE 1. Global Cardiovascular Genetic Testing Market, report scope
TABLE 2. Global Cardiovascular Genetic Testing Market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Cardiovascular Genetic Testing Market estimates & forecasts by Disease 2022-2032 (USD Billion)
TABLE 4. Global Cardiovascular Genetic Testing Market estimates & forecasts by Technology 2022-2032 (USD Billion)
TABLE 5. Global Cardiovascular Genetic Testing Market estimates & forecasts by Testing Type 2022-2032 (USD Billion)
TABLE 6. Global Cardiovascular Genetic Testing Market estimates & forecasts by Application 2022-2032 (USD Billion)
TABLE 7. Global Cardiovascular Genetic Testing Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Cardiovascular Genetic Testing Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Cardiovascular Genetic Testing Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Cardiovascular Genetic Testing Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Cardiovascular Genetic Testing Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Cardiovascular Genetic Testing Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Cardiovascular Genetic Testing Market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Cardiovascular Genetic Testing Market by region, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Cardiovascular Genetic Testing Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Cardiovascular Genetic Testing Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 17. U.S. Cardiovascular Genetic Testing Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 18. Canada Cardiovascular Genetic Testing Market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Cardiovascular Genetic Testing Market estimates & forecasts by segment 2022-2032 (USD Billion)
TABLE 20. Canada Cardiovascular Genetic Testing Market estimates & forecasts by segment 2022-2032 (USD Billion)
…..
This list is not complete; the final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Cardiovascular Genetic Testing Market, research methodology
FIG 2. Global Cardiovascular Genetic Testing Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods.
FIG 4. Global Cardiovascular Genetic Testing Market, key trends 2023
FIG 5. Global Cardiovascular Genetic Testing Market, growth prospects 2022-2032
FIG 6. Global Cardiovascular Genetic Testing Market, Porter’s 5 force model
FIG 7. Global Cardiovascular Genetic Testing Market, PESTEL analysis
FIG 8. Global Cardiovascular Genetic Testing Market, value chain analysis
FIG 9. Global Cardiovascular Genetic Testing Market by segment, 2022 & 2032 (USD Billion)
FIG 10. Global Cardiovascular Genetic Testing Market by segment, 2022 & 2032 (USD Billion)
FIG 11. Global Cardiovascular Genetic Testing Market by segment, 2022 & 2032 (USD Billion)
FIG 12. Global Cardiovascular Genetic Testing Market by segment, 2022 & 2032 (USD Billion)
FIG 13. Global Cardiovascular Genetic Testing Market by segment, 2022 & 2032 (USD Billion)
FIG 14. Global Cardiovascular Genetic Testing Market, regional snapshot 2022 & 2032
FIG 15. North America Cardiovascular Genetic Testing Market 2022 & 2032 (USD Billion)
FIG 16. Europe Cardiovascular Genetic Testing Market 2022 & 2032 (USD Billion)
FIG 17. Asia-Pacific Cardiovascular Genetic Testing Market 2022 & 2032 (USD Billion)
FIG 18. Latin America Cardiovascular Genetic Testing Market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Cardiovascular Genetic Testing Market 2022 & 2032 (USD Billion)
FIG 20. Global Cardiovascular Genetic Testing Market, company market share analysis (2023)
…..
This list is not complete; the final report does contain more than 50 figures. The list may be updated in the final deliverable.
